Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05818072
NA

The Prevalence, Risk Factors and Optimal Biopsy Protocol of BE

Sponsor: E-DA Hospital

View on ClinicalTrials.gov

Summary

Detections of goblet cells and dysplasia are crucial for diagnosis and determining the surveillance program of Barrett's esophagus (BE). However, the optimal biopsy numbers and their yield rates of intestinal metaplasia (IM) and dysplasia are still uncertain, especially in Asia. The aim of this study was to determine the optimal biopsy protocol of BE.

Official title: The Prevalence, Risk Factors and Optimal Biopsy Protocol of Barrett's Esophagus in Taiwan - A Prospective Randomized Study

Key Details

Gender

All

Age Range

20 Years - Any

Study Type

INTERVENTIONAL

Enrollment

165

Start Date

2023-03-13

Completion Date

2026-12-31

Last Updated

2023-05-11

Healthy Volunteers

No

Interventions

PROCEDURE

One biopsy

To do one biopsy at the proximal part of the longest columnar-lined esophagus.

PROCEDURE

Three biopsy

To do three biopsy at the proximal, middle and distal part of the longest columnar-lined esophagus.

PROCEDURE

Seattle protocol

To do 4-quadrant biopsy every 1-2 cm at the esophagogastric junction. Seattle protocol has been considered as the gold standard biopsy protocol for patients with suspected Barrett's Esophagus.

DEVICE

Endoscopy

The participants will receive meticulous endoscopic examination with narrow-band imaging.

Locations (1)

E-DA Hospital

Kaohsiung City, Taiwan